We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 24, 2020

Visceral Adiposity and Glucoregulatory Peptides Are Associated With Susceptibility to Type 2 Diabetes

Obesity 

 

Additional Info

Obesity 
Visceral Adiposity and Glucoregulatory Peptides Are Associated With Susceptibility to Type 2 Diabetes: The TOFI_Asia Study
Obesity 2020 Oct 10;[EPub Ahead of Print], IR Sequeira, W Yip, L Lu, Y Jiang, R Murphy, L Plank, S Zhang, H Liu, CL Chuang, G Vazhoor-Amarsingh, G Cooper, S Poppitt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading